CALMJuly 13, 2026 at 7:26 PM UTCFood, Beverage & Tobacco

Cal-Maine's Mix Shift Progresses, But Earnings Still Stuck in Egg Cycle Doldrums

Read source article

What happened

Cal-Maine Foods' transition to specialty eggs and prepared foods is gaining traction, with specialty eggs now over 50% of shell egg sales and prepared foods surging 441% YoY to 10% of sales, providing a buffer against cyclical egg price lows. The company maintains a fortress balance sheet with $1.1 billion net cash, supporting organic growth and opportunistic M&A. However, the DeepValue report maintains a WAIT rating, citing that shell eggs still represent 85.8% of sales and the core earnings driver remains realized egg pricing, which is currently at depressed levels of $1.766/dozen. The antitrust overhang, while seemingly resolved with no fines, still requires court approval and carries ongoing compliance costs. Until sequential pricing improves and prepared foods shows meaningful gross margin contribution, the risk/reward does not favor entry at current levels near $80.

Implication

While Cal-Maine's shift to specialty eggs and prepared foods is structurally positive, the core shell egg business remains in a downcycle with pricing at $1.766/dozen. The antitrust settlement removes a headline risk but imposes ongoing compliance costs. The company's net cash and buyback program provide downside support, but earnings power remains tied to commodity prices. The bull case for prepared foods requires proof of margin expansion beyond revenue growth. Thus, we recommend waiting for one to two quarters of sequential pricing improvement and prepared foods gross margin disclosure before establishing a position.

Thesis delta

The new article's bullish stance on Cal-Maine's mix shift and balance sheet is acknowledged, but the DeepValue report's WAIT rating reflects the reality that shell eggs dominate earnings and pricing remains weak. The thesis shifts from cautious improvement to requiring concrete evidence of stabilization before turning bullish. Until then, the risk of prolonged low pricing outweighs the benefits of diversification and net cash.

Confidence

Moderate